Integrated Pharmaceuticals, Inc.
INTP · Other OTC · USD
0,00USD
0,00 (0,00 %)Stand 21. Juni, 15:11
Kennzahlen
- Eröffnung
- 0,00
- Vortag
- 0,00
- Tagesspanne
- 0,00 – 0,00
- 52 Wochen
- 0,00 – 0,0001
- Volumen
- 2000
- Ø Volumen
- 0
- Börsenwert
- 1787 $
- KGV
- –
- Gewinn je Aktie (TTM)
- –
- Dividendenrendite
- –
- Beta
- 5,4
- Nächste Zahlen
- –
Finanzen
Gerade nicht verfügbar.
Bewertung
Gerade nicht verfügbar.
Analysten
Einstufungen
Gerade nicht verfügbar.
Kursziel
Gerade nicht verfügbar.
Quartalszahlen
| Gewinn je Aktie · Erwartet |
|---|
| Gewinn je Aktie · Tatsächlich |
| Abweichung |
| Umsatz · Tatsächlich |
Dividenden und Splits
Keine Dividenden gezahlt.
Aktiensplits
- 16. Juni 20031:4
- 20. Sept. 20001:4
- 18. Dez. 19981:2
- 16. Sept. 19981:6
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
–
Vergleichbare Unternehmen
BLEVFBeleave Inc.0,00+900,00 %
EPRSQEPIRUS Biopharmaceuticals, Inc.0,00−99,00 %
GNRSThe Greenrose Holding Company Inc.0,0001−50,00 %
GWHPGlobal WholeHealth Partners Corporation0,00−90,00 %
MLTOMEDirect Latino, Inc.0,00010,00 %
RXEIRxElite, Inc.0,00010,00 %
TAUGTauriga Sciences, Inc.0,000,00 %
WLNSFDiscover Wellness Solutions Inc.0,000,00 %
Über das Unternehmen
Integrated Pharmaceuticals, Inc., established in 1969 and based in Fitchburg, Massachusetts, operates across the United States, focusing on the creation and manufacturing of specialized chemicals and nutritional supplements. The company's diverse portfolio includes compounds and nutraceuticals scientifically proven to offer therapeutic or nutritive benefits for humans, plants, and animals. It also pioneers advancements in production methods for potent pharmaceutical ingredients, encompassing active small molecular drugs and products derived from recombinant DNA technology. Additionally, Integrated Pharmaceuticals supplies calcium enrichments designed for integration into a wide array of consumables, such as soft drinks, coffee, tea, soups, powdered sauces, various other beverages, and enhanced bottled water. Its products are distributed via a network of wholesale distributors and direct-to-consumer retailers. The firm adopted its current name in September 2011, having previously operated as Digital Caddies, Inc.
Führung
- Nilu Prasad ChatterjeeVice President of Research & Development, Treasurer and Director
- Edward D. FurtadoVice-President of Operations, Secretary and Director
- David H. SmithExecutive Chairman and Chief Financial Officer
- CEO
- David H. Smith II
- Mitarbeitende
- 4
- Hauptsitz
- Fitchburg, MA, US
- Sektor
- Healthcare
- Branche
- Drug Manufacturers - Specialty & Generic
- Börsengang
- 6. Dez. 2000
Nachrichten
Gerade keine Nachrichten zu diesem Unternehmen.
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.